Goodwill of Akebia Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Akebia Therapeutics, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Akebia Therapeutics, Inc. Goodwill for the quarter ending 31 Dec 2025 was $59,044,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Akebia Therapeutics, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $59,044,000 $0 0% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $59,044,000 $0 0% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $59,044,000 $0 0% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $59,044,000 $0 0% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $59,044,000 $0 0% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $59,044,000 $0 0% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $59,044,000 $0 0% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $59,044,000 $0 0% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $59,044,000 $0 0% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $59,044,000 $0 0% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $59,044,000 $0 0% 30 Jun 2023 10-Q 28 Aug 2023 2023 Q2
Q1 2023 $59,044,000 $0 0% 31 Mar 2023 10-Q 28 Aug 2023 2023 Q2
Q4 2022 $59,044,000 $0 0% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $59,044,000 +$3,991,000 +7.2% 30 Sep 2022 10-K/A 28 Aug 2023 2022 FY
Q2 2022 $59,044,000 +$3,991,000 +7.2% 30 Jun 2022 10-Q 28 Aug 2023 2023 Q2
Q1 2022 $59,044,000 +$3,991,000 +7.2% 31 Mar 2022 10-Q 28 Aug 2023 2023 Q2
Q4 2021 $59,044,000 +$3,991,000 +7.2% 31 Dec 2021 10-K/A 28 Aug 2023 2022 FY
Q3 2021 $55,053,000 $0 0% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $55,053,000 $0 0% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $55,053,000 $0 0% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $55,053,000 $0 0% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $55,053,000 $0 0% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $55,053,000 $0 0% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $55,053,000 $0 0% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $55,053,000 $0 0% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $55,053,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $55,053,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $55,053,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $55,053,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.